Gerresheimer Opens new High-Tech Production Facility for Pharma Glass in
China
DÜSSELDORF, May 27 /PRNewswire-AsiaNet/ --
- Now Seven Plants in China
The Gerresheimer Group today opened a new plant for
pharmaceutical glass packaging in China. The high-tech production
facility constructed in Danyang (Jiangsu Province) covers 16,000 square
meters. Specializing in high-quality pharmaceutical vials and cartridges
for injection systems it serves the pharma & life science industry on
both a local and international level. Dr. Axel Herberg, CEO of
Gerresheimer AG, describes the investment as a very important strategic
step for further business expansion in Asia. In China, Gerresheimer now
operates seven production plants for highly specific glass and plastic
products.
The new facility belongs to Gerresheimer Shuangfeng, a Chinese
subsidiary of the Group, which was acquired in 2006 and now already has
production plants in three locations with a total of more than 150
production lines. With investment in future-oriented technologies and a
high-quality range of vials, ampoules and cartridges, it has in just a
few years developed into the market leader in China, said Dr. Max Raster,
member of the Management Board of Gerresheimer AG with responsibility for
the Tubular Glass Division, at the opening ceremony on May 29, 2009.
"'Top quality produced in China' is the corporate philosophy
here which binds us directly to the ambitious objectives for development
of the local economy and the Jiangsu region," Raster said. At the gala
opening he joined Chao Xingsong, the Managing Director of Gerresheimer
Danyang, in welcoming representatives from the world of politics and the
administration as well as a large number of national and international
customers who clearly showed they were impressed by the high technical
standard.
The state-of-the-art plant in the up-and-coming city with
800,000 inhabitants just 250 kilometers to the west of Shanghai is of
outstanding strategic importance for the globally active Gerresheimer
Group. A key area of focus for it is the rapidly growing Asian pharma
market with its constantly rising quality demands in terms of packaging
and drug delivery. In the unanimous assessment of experts, China is
already the fifth largest pharma market in the world.
In parallel with its local status as a technology advanced
pharma glass plant the Danyang facility offers ideal conditions and
flexible expansion possibilities to enable it to supply customers with
high-quality specialist products in neighboring Asian countries and other
market regions as well. "We work at the highest level of internationally
recognized quality standards," Raster stresses. The technical production
processes are for example monitored by in-line camera systems - a product
control process which is by no means universal industry practice in China
or elsewhere. The clean-room concept also reflects the latest development
status.
In Danyang, which has for years been regarded as a highly
attractive industrial location for foreign investors in particular,
Gerresheimer Shuangfeng also has a second production plant exclusively
for pharmaceutical vials. In addition, the company manufactures vials and
ampoules in Zhenjiang, also in the Province of Jiangsu. Four other plants
of the Gerresheimer Group also manufacture in the country. In total,
Gerresheimer employs around 1,500 people in China.
About Gerresheimer
Gerresheimer employs around 10,000 people in 42 locations in
Europe, America and Asia. In the financial year 2008, worldwide sales
totalled EUR1.06bn. The product portfolio ranges from pharmaceutical
vials made of glass and plastic through to complex drug-delivery systems
for the pharma & life science industry. These include sterile syringes,
inhalers and other system-based approaches for safe dosage and
application of medications. The Group enjoys a leading position in
markets which are characterised by high technical and regulatory
barriers.
Contact Press
Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49-211-6181-250
Fax +49-211 6181-241
e-mail b.lingenberg@gerresheimer.com
Contact Investor Relations
Anke Linnartz
Director Corporate Investor Relations
Phone +49-211-6181-314
Fax +49-211-6181-121
e-mail a.linnartz@gerresheimer.com
SOURCE: Gerresheimer AG
NEWS 
